Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Ustekinumab News Monitoring

Get by Email • RSS

Published on Mar 25, 2025

Celltrion Wins Costco Formulary Listing for its Recently Launched Ustekinumab

Last week, we reported Celltrion’s U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen’s STELARA® (ustekinumab). According to Celltrion, STEQEYMA® is being sold at a wholesale acquisition cost (WAC) list price at an 85% discount to the …

Source: JD Supra - Label Pending
Published on Mar 25, 2025

Impact of Treatment Interruption on the Effectiveness of Interleukin (IL)-17A Inhibitors in Plaque Psoriasis: A ...

Introduction Plaque psoriasis is a chronic, recurrent, immune-mediated inflammatory skin disease.1 The lesions show red scaly plaques, which are common in elbows, knees, trunk, scalp, etc. Plaque psoriasis affects about 29.5 million adults worldwide, and …

Source: Dove Medical Press - Neutral
Published on Mar 21, 2025

FDA Approves Tremyfa to Treat Active Crohn’s Disease

The FDA has approved Johnson & Johnson’s supplemental application for Tremfya (guselkumab) to treat adults with moderately to severely active Crohn’s disease (CD), a chronic inflammatory condition of the gastrointestinal tract. Tremfya is available as …

Source: Managed Healthcare Executive - Neutral
Published on Mar 21, 2025

J&J adds to IL-23 options in Crohn's after FDA approval

Johnson & Johnson's IL-23 inhibitor Tremfya has been approved by the FDA as a treatment for Crohn's disease, becoming the first drug in the class available in both intravenous and subcutaneous formulations for the inflammatory bowel disease ( …

Source: pharmaphorum - Neutral
Published on Mar 21, 2025

Guselkumab Receives FDA Approval for Adults With Moderately to Severely Active Crohn Disease

The FDA has approved guselkumab (Tremfya; Johnson & Johnson), the first and only IL-23 inhibitor that offers both subcutaneous (SC) and intravenous (IV) induction options, for the treatment of adults with moderately to severely active Crohn disease (CD …

Source: Pharmacy Times - Neutral
Published on Mar 21, 2025

FDA Approves Guselkumab (Tremfya) For Crohn Disease

The US Food and Drug Administration (FDA) has approved guselkumab (Tremfya) for the treatment of adults with moderately to severely active Crohn disease. According to a March 20, 2025 announcement from Johnson and Johnson, the approval is based on data …

Source: Consultant Live - Label Pending
Published on Mar 21, 2025

FDA Approves Guselkumab for Adult Patients With Crohn Disease

The FDA approved guselkumab (Tremfya; Johnson & Johnson) for adult patients with moderate to severe active Crohn disease.1 The approval marks the first and only IL-23 inhibitor that offers both subcutaneous and intravenous induction options. “Tremfya …

Source: The American Journal of Managed Care - Neutral
Published on Mar 21, 2025

Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara

March 21, 2025 2 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Tremfya is the first …

Source: Healio News - Neutral
Published on Mar 21, 2025

Johnson & Johnson’s Tremfya granted FDA approval to treat Crohn’s disease

Johnson & Johnson’s (J&J) Tremfya (guselkumab) has been approved by the US Food and Drug Administration (FDA) to treat adults with moderately to severely active Crohn’s disease (CD). CD is one of the two main forms of inflammatory bowel disease ( …

Source: PMLiVE - Neutral
Published on Mar 22, 2025

The HCPFive: Top News for Healthcare Providers from the Week of 03/16

Welcome to The HCPFive, your go-to roundup for the latest healthcare news and breakthroughs, curated specifically for busy healthcare professionals. Each week, we highlight 5 key developments or headlines from healthcare that you need to know—whether it…

Source: Consultant Live - Label Pending
Published on Mar 21, 2025

Guselkumab (Tremfya) Wins Approval for Crohn Disease, Fourth Indication for Immune-Mediated Diseases

The US FDA on Thursday approved guselkumab (Tremfya; Johnson & Johnson) for the treatment of adults with moderately to severely active Crohn disease (CD). The approval follows the agency's September 2024 green light for the dual-acting monoclonal …

Source: Patient Care - Label Pending
Published on Mar 21, 2025

The Top 5 Biosimilar Articles for the Week of March 17

Number 5: Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite challenges posed by differing national requirements and regulatory frameworks, according to review authors. Number 4: Biocon …

Source: The Center for Biosimilars - Label Pending
Published on Mar 21, 2025

Vogt-Koyanagi-Harada Syndrome: An Update

Vogt-Koyanagi-Harada syndrome, or VKH, is a well-described, rare cause of bilateral granulomatous panuveitis, as well as a spectrum of other symptoms that may occur in other organs containing melanocytes.1 It can be challenging to diagnose, since it has a …

Source: Review of Ophthalmology - Neutral
Published on Mar 25, 2025

Fever and Chest Pain in an 8-Year-Old Girl

Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians, but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using …

Source: Medscape - Neutral
Published on Mar 24, 2025

Celltrion’s Stelara biosimilar wins Costco formulary listing

Celltrion’s autoimmune disease treatment Steqeyma (ustekinumab) is set to be sold at Costco pharmacies across the U.S. under a new listing agreement with Costco Health Solutions, the pharmacy benefit manager (PBM) arm of the retailer. As part of the …

Source: Korea Biomedical Review - Neutral
Published on Mar 24, 2025

Celltrion's Steqeqma to Be Sold at Costco in the U.S.

Celltrion's autoimmune disease treatment, Steqeqma (generic name: Ustekinumab), will be sold at Costco, a major retail chain in the United States. This achievement comes just two weeks after Steqeqma's launch in the U.S. market. On March 22 (local …

Source: Korea IT Times - Neutral
Published on Mar 24, 2025

Formycon Invites To Conference Call On The Results Of The Financial Year 2024 And Announces Participation In ...

EQS-News: Formycon AG / Key word(s): Conference/Annual Report Formycon invites to conference call on the results of the financial year 2024 and announces participation in international investor conferences in the 2nd quarter of 2025 24.03.2025 …

Source: MENAFN - Uncategorized

05 days 22:41:59

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 13:44 GMT

Dermatological Drugs Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034

The Business Research Company’s Dermatological Drugs Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 25, 2025 /⁨EINPresswire.com⁩/ -- The unveiling of the dermatological drugs global …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 14:09 GMT

Top Growth Driver In The Chromatography Instrumentations Market 2025: Impact Of The Growing Pharmaceutical Industry

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! LONDON, GREATER LONDON, UNITED KINGDOM, March 25, 2025 /⁨EINPresswire.com⁩/ -- Did you know that the chromatography instrumentations …

Distribution channels: Business & Economy, Companies ...

Published on March 25, 2025 - 23:00 GMT

Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research ...

ROCKVILLE, Md. and SUZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 15:25 GMT

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced …

Distribution channels: Business & Economy, Companies ...

Published on March 25, 2025 - 20:40 GMT

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in patients with high-grade serous ovarian cancer (HGSOC) Three additional posters highlighting the potential for broad …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 20:30 GMT

ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 20:01 GMT

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and Novel Mechanism of Action Registration Phase 3 Clinical …

Distribution channels:
Published on March 25, 2025 - 15:23 GMT

Cholinesterase Che Inhibitors Global Market Report 2025: A Comprehensive Overview Of Emerging Trends And Growing

Enjoy a flat 15% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out! LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /⁨EINPresswire.com⁩/ -- The year 2024 saw the cholinesterase ChE …

Distribution channels: Business & Economy, Companies ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 797,183,225 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 26, 2025 - 05:01 GMT

Global Guillain Barre Syndrome Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

The Business Research Company's Guillain-Barre Syndrome Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 26, 2025 - 05:01 GMT

In-Depth Analysis Of The Global Growth Hormone Deficiency Market: Key Drivers, Trends, Growth And Forecast 2025-2034

The Business Research Company's Growth Hormone Deficiency Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 26, 2025 - 00:13 GMT

Infinnium Launches BECProfiler™: A Cutting-Edge Solution to Automate Business Email Compromise Investigations

Business Email Compromise Investigations are time consuming, manual, and costly. BECProfiler™ reduces the time to minutes and lowers cost. CHANTILLY, VA, UNITED STATES, March 26, 2025 /⁨EINPresswire.com⁩/ -- Infinnium, a leader in AI-driven data …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 26, 2025 - 00:00 GMT

Next Featured Solution Provider for Mostly Medicaid StarSearch Series: Rosarium Health (Show date- April 18th, 2025)

The next installment of Medicaid StarSearch features Rosarium Health founder Cameron Carter and his vision to unlock the home modification benefit for members. BIRMINGHAM, AL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- MostlyMedicaid …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 26, 2025 - 00:00 GMT

C&F Plumbing Expands with New Location in Mountain Lakes, NJ

C&F Plumbing, serving North Jersey since 2009, expands to Mountain Lakes to better serve Morris and Sussex Counties with expert plumbing services. SPARTA, NJ, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- C&F Plumbing, a trusted …

Distribution channels: Business & Economy, Companies ...
Published on March 25, 2025 - 21:58 GMT

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board

HeartLung Technologies proudly announces Dr. Zahi A. Fayad, PhD, joining the advisory board to enhance AI-driven preventive healthcare solutions. HOUSTON, TX, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is proud to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 25, 2025 - 21:00 GMT

Blueberries Medical Announces C$1 Million Non-Brokered Private Placement

Blueberries secures C$1.05M in private placement led by Terraflos to fund expansion and operations across Latin America. Blueberries Medical Corp (OTCMKTS:BBRRF) TORONTO, ONTARIO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Blueberries Medical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 21:00 GMT

GO2 for Lung Cancer Forms the Global Advisory Council to Support Its Mission to Confront Lung Cancer

WASHINGTON, DC, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- GO2 for Lung Cancer (GO2) announced it established the Global Advisory Council (GAC), a new group that brings together scientists, medical specialists, and other healthcare …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 20:45 GMT

Accessia Health to Host Free Medicare Part D Webinar; Highlight New Survey Data on What is Working and What Needs Fixing

Educational gap may persist for Medicare recipients and caregivers; over half don’t recall receiving any information on new cost savings plan MIDLOTHIAN, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- What: Join patient advocates, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 20:27 GMT

Robot Industries Launches RiA Agents AI: A Game-Changer in Intelligent Automation

Robot Industries introduces RiA AI agents to revolutionize business automation and enhance human potential! BERLIN, GERMANY, March 25, 2025 /⁨EINPresswire.com⁩/ -- Robot Industries is proud to announce the launch of RiA - AI Agents for Business …

Distribution channels: Automotive Industry, Banking, Finance & Investment Industry ...
Published on March 25, 2025 - 20:00 GMT

CloudAtlas AI Guardian Now Available on Microsoft Azure Marketplace

UnifyCloud protects your AI investments with CloudAtlas AI Guardian, now accessible on Microsoft Azure Marketplace for secure and responsible AI integration. REDMOND, WA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- UnifyCloud, a global …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 19:32 GMT

Singota Solutions Expands European Footprint to 3 Sites, Adds New State-of-the-Art Facility in Balerna, Switzerland

Singota Solutions expands in Europe with new GDP-certified Balerna, Switzerland site, offering bonded warehousing & cold storage for pharma logistics. BLOOMINGTON, IN, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Singota Solutions, a …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 19:21 GMT

Titan Health Launches Groundbreaking Revenue Cycle Management as a Service (RCMaaS)

Innovative Offering Combines AI and Industry-Leading RCM Practices to Set New Benchmarks TUCSON, AZ, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Titan Health, a pioneer in high-performance revenue cycle management (RCM) services for the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 19:15 GMT

PathFree Technologies Joins Octane's LaunchPad SBDC Accelerator Program, Prepares for High-Stakes Fast Pitch Event

PathFree Technologies joins Octane’s LaunchPad SBDC Accelerator, preparing to pitch AI-driven healthcare solutions to top VCs and investors at Fast Pitch. IRVINE, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PathFree Technologies …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 25, 2025 - 18:38 GMT

Pleasanton Children’s Dentistry & Braces Unveils New State-of-the-Art Facility to Better Serve the Community

Pleasanton Children’s Dentistry & Braces opens a new building, expanding care to meet the growing needs of Pleasanton and surrounding areas. PLEASANTON, TX, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Pleasanton Children’s Dentistry …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 18:37 GMT

Safari Children’s Dentistry & Braces Celebrates Grand Opening of New Facility

Safari Children’s Dentistry & Braces opens a state-of-the-art facility, enhancing pediatric dental care for the San Antonio community. SAN ANTONIO, TX, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Safari Children's Dentistry & …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 18:37 GMT

Sunshine Pediatric Dentistry and Orthodontics Introduces a Specialty Boutique Store for Enhanced Dental Care Experience

Sunshine Pediatric Dentistry and Orthodontics unveils a specialty boutique store, offering a unique and enhanced dental care experience for patients. SAN ANTONIO, TX, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Sunshine Pediatric …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 18:07 GMT

Global Clinical Trial Support Services Market Report 2025: Trends, Size, Key Players & Future Outlook

The Business Research Company's Global Clinical Trial Support Services Market Report 2025: Trends, Size, Key Players & Future Outlook LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 25, 2025 - 18:00 GMT

Celebrating the Life of Healthcare Advocate and Trailblazing Public Servant Keysha Brooks-Coley

BOWIE, MD, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- With deep sorrow, the family of Okeysha “Keysha” Yashica Brooks-Coley announces her passing on March 15, 2025, at the age of 49. A beloved wife, mother, daughter, Keysha leaves behind …

Distribution channels: Healthcare & Pharmaceuticals Industry, U.S. Politics ...
Published on March 25, 2025 - 17:56 GMT

TTA Recognized on Training Industry’s 2025 Leadership Training Watch List

TTA is honored to be named to Training Industry’s Leadership Training Watch List for 2025, marking the eighth consecutive year of recognition. MARLBOROUGH, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TTA is honored to be named to …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...